StockData
Jaguar Health, Inc. logo

Jaguar Health, Inc. (JAGX) stock

JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 2/30
$2.82−0.71 (-20.00%)

Close on Oct 19, 2026Market cap $2.28MP/E –Yield –

Jaguar Health free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Jaguar Health's free cash flow for the twelve months ending Dec 31, 2024 was -$29.40M. For fiscal 2024 it was -$29.40M. The highest annual figure on record is -$5.41M in fiscal 2014.

Annual free cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$29.40M–
FY2022Dec 31, 2022-$33.18M–
FY2021Dec 31, 2021-$34.98M–
FY2020Dec 31, 2020-$15.29M–
FY2018Dec 31, 2018-$22.74M–
FY2016Dec 31, 2016-$14.52M–
FY2015Dec 31, 2015-$14.34M–
FY2014Dec 31, 2014-$5.41M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024-$7.83M–
Q3 FY2024Sep 30, 2024-$6.34M–
Q3 FY2023Sep 30, 2023-$6.79M–
Q2 FY2023Jun 30, 2023-$9.06M–
Q1 FY2023Mar 31, 2023-$9.95M–
Q4 FY2022Dec 31, 2022-$6.42M–
Q3 FY2022Sep 30, 2022-$8.53M–
Q4 FY2021Dec 31, 2021-$8.92M–
Q3 FY2021Sep 30, 2021-$9.43M–
Q4 FY2020Dec 31, 2020-$4.06M–
Q3 FY2020Sep 30, 2020-$2.92M–
Q2 FY2020Jun 30, 2020-$4.00M–
Q1 FY2020Mar 31, 2020-$4.30M–
Q4 FY2018Dec 31, 2018-$4.90M–
Q3 FY2018Sep 30, 2018-$2.81M–
Q4 FY2016Dec 31, 2016-$2.73M–
Q3 FY2016Sep 30, 2016-$3.39M–
Q2 FY2016Jun 30, 2016-$3.79M–

More Jaguar Health figures

See a number that looks wrong?